Rydapt has become proven being of advantage in patients with AML linked to an FTL3 mutation. The safety on the drugs was satisfactory in this kind of serious issue and was considered manageable. title = Discovery of PF-06928215 for a large affinity inhibitor of cGAS enabled by a novel fluorescence https://johno899wtt1.aboutyoublog.com/profile